Udaipur: A 16-year-old girl suffering from the rare and potentially life-threatening Anti-NMDA Receptor Encephalitis has made a remarkable recovery following advanced treatment at Geetanjali Hospital, Udaipur.

The teenager had spent nearly a month battling uncontrolled seizures, severe abnormal movements and a prolonged state of unconsciousness. Despite treatment elsewhere, her condition failed to improve. On reassessment at Geetanjali Hospital, a CSF test confirmed Anti-NMDA Receptor Encephalitis, enabling doctors to establish the underlying cause.

The treatment team, led by Dr. Anees Zukerwala, Head of the Department of Neurology, initially used rituximab and other standard therapies. When the expected response was not achieved, the team opted for bortezomib therapy, an advanced treatment approach in this complex neurological condition.

The response was remarkable. Within nearly two weeks of starting bortezomib therapy, the girl regained consciousness, her seizures stopped and the abnormal movements subsided. She was subsequently weaned off the ventilator, and her tracheostomy was also closed.

A six-month follow-up confirmed that the patient had recovered completely and returned to a normal life.

Dr. Zukerwala said the case highlights the importance of accurate diagnosis, continuous clinical reassessment and timely escalation to advanced therapies in patients with complex and life-threatening neurological disorders.

A month of uncertainty. A rare diagnosis. An advanced treatment—and ultimately, a new beginning.